Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
|
Mid-range Performer
911.7500
0.95
(
0.10
%)
NSE
Dec 16, 2025
15:31 PM
27.12% Fall from 52W High
Volume:
66,682
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
29 Apr 2024
911.75
0.10%
Glenmark Life Science
Buy:
Alivus Life Sciences Ltd.
by
ICICI Direct
Target: 1040
ICICI Direct
Number of FII/FPI investors decreased from 101 to 92 in Sep 2025 qtr
More from Alivus Life Sciences Ltd.
All Rapid Results
Recommended
Five stocks to buy from analysts this week - December 16, 2025
The Baseline |
16 Dec 2025, 06:03PM
Market closes lower as the rupee hits an all-time low
Trendlyne Marketwatch |
16 Dec 2025, 03:57PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021